<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04315363</url>
  </required_header>
  <id_info>
    <org_study_id>19-06-05</org_study_id>
    <nct_id>NCT04315363</nct_id>
  </id_info>
  <brief_title>Changing and Understanding Motivation to Increase Physical Activity Among Sedentary Older Adults: Daily Activity Study of Health</brief_title>
  <acronym>DASH</acronym>
  <official_title>Changing and Understanding Motivation to Increase Physical Activity Among Sedentary Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northeastern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northeastern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this six-week behavioral intervention, sedentary older adults will receive daily health&#xD;
      messaging via their smart phone to better understand their daily activities and emotions.&#xD;
      Participants undergo structural and functional brain imaging before and after the&#xD;
      intervention along with measures of their behavioral, emotional and thinking functions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This project will obtain data on the effects of a six week intervention designed to increase&#xD;
      subjects' motivation to increase their physical activity. Subjects will be randomized into&#xD;
      two different conditions to examine the efficacy of self-affirmation + positive messaging&#xD;
      versus a control group that receives negative messaging only on changes in physical activity.&#xD;
&#xD;
      We will also examine whether any differential physical activity or structured exercise&#xD;
      engendered in the two groups is maintained at 6 months post-intervention.&#xD;
&#xD;
      Secondary outcome measures will include a battery of cognitive, psychosocial, and&#xD;
      neuroimaging measures that are designed to explicate the mechanisms that underlie motivation&#xD;
      effects for physical activity in sedentary older adults.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 6, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total step count (average steps/day)</measure>
    <time_frame>Baseline; 6-week; 3-month follow-up</time_frame>
    <description>This metric quantifies the change in the average number of steps taken each day, from the baseline period to the 6-week and 6-month followup periods. It is a marker of change in habitual ambulatory activity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sedentary behavior (average min/day)</measure>
    <time_frame>Baseline; 6-week; 3-month follow-up</time_frame>
    <description>This metric quantifies the change in the average amount of time spent sedentary each day, from the baseline period to the 6-week and 6-month follow-up periods. It is a marker of time spent inactive.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiorespiratory fitness (V02 peak in mL/kg/min)</measure>
    <time_frame>Baseline; 6-week; 3-month follow-up</time_frame>
    <description>This metric quantifies the change in fitness from the baseline period to the 6-week and 6-month follow-up periods. Oxygen uptake (VO2) will be measured from expired air samples taken at 15 second intervals until a peak VO2, the highest VO2, is attained at the point of test termination due to symptom limitation and/or volitional exhaustion. Fitness is assessed by maximal graded exercise testing.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive functioning</measure>
    <time_frame>Baseline; 6-week; 3-month follow-up</time_frame>
    <description>Executive function, complex attention and processing speed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Affective processing</measure>
    <time_frame>Baseline; 6-week; 3-month follow-up</time_frame>
    <description>Measure of affect and mood (i.e., geriatric depression scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Structural and functional imaging</measure>
    <time_frame>Baseline; 6-week; 3-month follow-up</time_frame>
    <description>Structural brain imaging will be used to measure brain morphology including cortical thickness, hippocampal subfields, and white matter structure.&#xD;
Functional brain imaging will be used to measure changes in brain activity at rest.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Brain MRI and Motivational Behavioral Intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Brain MRI and Control Behavioral Intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Motivational MRI and Behavioral Intervention</intervention_name>
    <description>Motivational messaging delivered during a functional brain MRI scan and with daily messaging</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control MRI and Behavioral Intervention</intervention_name>
    <description>Control messaging delivered during a functional brain MRI scan and with daily messaging</description>
    <arm_group_label>Active control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age range 60-95&#xD;
&#xD;
          -  Not exercising more than 150 minutes of moderate/vigorous intensity per week or&#xD;
             sitting more than 8 hours per day&#xD;
&#xD;
          -  No contraindications to MRI (if opting for MRI)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Primary care physician does not approve additional physical activity&#xD;
&#xD;
          -  Inability to ambulate without assistive device&#xD;
&#xD;
          -  Any unstable medical condition&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maiya Geddes, Dr.</last_name>
    <phone>616259</phone>
    <phone_ext>2973</phone_ext>
    <email>mgeddes@bwh.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Meishan AI, BS</last_name>
    <phone>858265</phone>
    <phone_ext>7288</phone_ext>
    <email>ai.me@northeastern.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Northeastern University</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maiya Geddes, Dr.</last_name>
      <phone>616-259-2973</phone>
      <email>mgeddes@bwh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Arthur Kramer, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Susan Whitfield Gabrieli, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charles Hillman, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>February 26, 2020</study_first_submitted>
  <study_first_submitted_qc>March 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2020</study_first_posted>
  <last_update_submitted>June 25, 2021</last_update_submitted>
  <last_update_submitted_qc>June 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northeastern University</investigator_affiliation>
    <investigator_full_name>Maiya Geddes</investigator_full_name>
    <investigator_title>Affiliate Associate Professor</investigator_title>
  </responsible_party>
  <keyword>motivation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

